Research Focus: MEN-2B treatment outcomes and letrozole for delayed puberty

PODCAST
April 1, 2019
Adrenal disorders, Puberty, Thyroid disorders

In our first edition, Professor Frederic Castinetti discussing the results of an international collaboration to study the natural history and treatment outcomes of multiple endocrine neoplasia type 2B, and Professor Martin Savage comments on a randomized trial of letrozole versus testosterone in boys with constitutional delay of growth and puberty.

Martin Savage

Programme Director

Browse Topics

Adrenal disorders
Bone disorders
Obesity/Type 2 diabetes
Pituitary/growth disorders
Puberty disorders
Thyroid disorders
Type 1 diabetes

Sign up for eAlerts

Be the first to hear about new resources and content by signing up to receive our eAlerts.

Please provide your details:

Email address(Required)

First name(Required)

Last name(Required)

Country(Required)

Declaration(Required)

I confirm that I have read and accept the privacy policy, and agree to receive new content alerts for this site.

Name

This field is for validation purposes and should be left unchanged.